By Vikas P. Sukhatme ~ Originally published in Frontiers in Pharmacology ~ April 20, 2021 Fluvoxamine is a well-tolerated, widely available, inexpensive selective serotonin reuptake inhibitor that has been shown in a small, double-blind, placebo-controlled, randomized...

read more